EUVIMEDEUVIMED entdecken
Crossref

Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma

Xin-Zhuo Zhan, Tian-Hua Wei, Chen Huang, Hui Yu, Xiao-Li Chen, Xiang-Tu Kong, Zhi-Hao Shang, Shan-Liang Sun, Meng-Yi Lu, Hai-Wen Ni

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-10999-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Xin-Zhuo Zhan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China. Hauptthemen laut MEDLINE: Quercetin, Janus Kinase 2, Lymphoma, Large B-Cell, Diffuse, STAT3 Transcription Factor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Innovation and entrepreneurship training program for college students, The Open Project of State Key Laboratory of Natural Medicines, The fourth batch of the National Excellent Talent Training Program of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Qiling Baitouweng Tang (QLBTWT) is a traditional clinical formula for treating diffuse large B-cell lymphoma (DLBCL), but its molecular action is not fully understood. This research is utilized in silico analysis and liquid chromatography tandem mass spectrometry (LC‒MS/MS) to identify the active constituents of QLBTWT with anti-DLBCL properties and their targets. The study identified 14 compounds, including quercetin, naringenin, and astilbin, as potentially effective against DLBCL. Molecular modeling highlighted the favorable interaction of quercetin with the JAK2 protein. In vitro studies confirmed the ability of quercetin to inhibit DLBCL cell growth and migration while inducing apoptosis and causing G2/M phase cell cycle arrest. Molecular dynamics simulations revealed that quercetin binds to JAK2 as a type II inhibitor. In vivo studies in U2932 xenograft models demonstrated that QLBTWT inhibited tumor growth in a dose-dependent manner, which was associated with the JAK2/STAT3 signaling pathway. Overall, this study elucidates the therapeutic effect of QLBTWT on DLBCL through quercetin-mediated suppression of the JAK2/STAT3 pathway, offering novel therapeutic insights for DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinJanus Kinase 2Lymphoma, Large B-Cell, DiffuseSTAT3 Transcription FactorSignal TransductionDrugs, Chinese HerbalHumansAnimalsCell Line, TumorMiceCell ProliferationApoptosisXenograft Model Antitumor AssaysMolecular Docking SimulationCell MovementMolecular Dynamics Simulation

Stichwörter der Autor:innen

Diffuse large B-cell lymphomaJanus kinase 2/signal transducer and activator of transcription 3Qiling Baitouweng TangQuercetin

Substanzen

QuercetinJanus Kinase 2STAT3 Transcription FactorJAK2 protein, humanSTAT3 protein, humanDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
  • National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrializa…
  • Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, China. ssun@njucm.edu.cn.
  • Department of Biostatistics, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing, 211166, China. mylunjyk@njmu.edu.cn.

Förderung

  • Innovation and entrepreneurship training program for college students
  • The Open Project of State Key Laboratory of Natural Medicines
  • The fourth batch of the National Excellent Talent Training Program of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine…
  • Project of Jiangsu Administration of Traditional Chinese Medicine
  • A key project of the Jiangsu Provincial Health Commission
  • Natural Science Foundation of Nanjing University of Chinese Medicine

Zitieren

APA

Zhan, X. Z., Wei, T. H., Huang, C., Yu, H., Chen, X. L., Kong, X. T., Shang, Z. H., Sun, S. L., Lu, M. Y., & Ni, H. W. (2025). Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma. Molecular Diversity. https://doi.org/10.1007/s11030-024-10999-2

Vancouver

Zhan XZ, Wei TH, Huang C, Yu H, Chen XL, Kong XT, et al. Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma. Molecular Diversity. 2025. doi:10.1007/s11030-024-10999-2

BibTeX
@article{Zhan2025,
  author = {Zhan, Xin-Zhuo and Wei, Tian-Hua and Huang, Chen and Yu, Hui and Chen, Xiao-Li and Kong, Xiang-Tu and Shang, Zhi-Hao and Sun, Shan-Liang and Lu, Meng-Yi and Ni, Hai-Wen},
  title = {Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-10999-2}
}
Kostenlos starten →